with the High Sponsorship of CPLP
The Biomedical and Biopharmaceutical Research journal (BBR) is a peer-reviewed, bilingual, international scientific publication created primarily to foster societal progress through health-related knowledge within the Portuguese speaking countries around the world. BBR was recently distinguished with the High Sponsorship of CPLP (Community of Portuguese Speaking Countries).
Health is critical for progress, and among the countries which share the Portuguese language and culture, this progress is not uniform. BBR offers the opportunity to address specific issues in these communities, by its own observers, with a permanent translational purpose to improve education and societal advancement. However, BBR is not exclusively for Portuguese speaking authors, and many of the challenges faced within the lusofone universe are shared with the rest of the world. We believe our views, experiences, and achievements – including the Portuguese speaking diaspora spread all over the world – can positively impact the world at large.
Within the fields of biomedical and biopharmaceutical sciences, the research interests of BBR are focused on environmental, social, behavioural, technological and political perspectives to promote human health and prevent disease in the individual and their communities.
BBR is an independent open-access publication, free for readers, focused in high quality research, promoting diversity, equity and equality , and guided by the highest ethical standards in human medical research.
BBR scope intends to reflect a fundamental / integrative research character, serving as a platform for knowledge exchange by publishing original papers, reviews, and case reports. BBR is focused in, but not limited to, the following subjects
• Public, Community, Environmental, and Occupational Health
• Nutrition and Health Promotion
• Development of (drug/non-drug) Delivery Systems,
• Modelling of in vivo Systems, Pharmacology, Molecular Mechanisms, and Therapeutics
• Natural Bioactives
At the Editor’s discretion, research on more applied topics may be included.
BBR seeks to promote the application of research into practice and especially values open collaborative cross-disciplinary science. BBR welcomes papers with translational potential in biomedicine and biopharmaceutics issues, seeking research with a focus in new perceptions on structural issues impacting health policies and systems, new molecules (natural or designed) with potential to address main disease burdens, or new mechanistic insights into models or processes to study disease mechanisms with potential impact in diagnostic and/or therapeutics.
Editors do not receive any salary for their work at BBR. Even so, Editors are required to declare all relevant competing interests and are excluded from participation in the review of any submission for which they have a competing interest.
BBR does not charge costs or fees for submission and publication of manuscripts from Portuguese-language speaking authors. For other authors, only an English version is required for submission. However, BBR does not accept automatic translations (GoogleTranslate, DeepL, others) meaning that the Portuguese version will be a direct responsibility of the Editorial Office. In this case, a fee will be charged to ensure that purpose +here+
Indexing and Archiving
See publishing details including ISSN for all BBR journal titles freely accessible +here+
BBR is present in several databases, including LATINDEX, Scopus, Google Scholar, REDIB, and mEDRA.
Application to other databases is in progress.
Ethics and Good Publication Practices
BBR takes very seriously all its duties and ethical responsibilities regarding all stages of publication. Our editorial options and policies are detailed +here+
BBR is continuously working to promote diversity a concern addressed by a constant (not always well succeeded) search for authors and editors from minor or in-developing communities within the “lusofone” countries. The same awareness has shaped the expansion of our editorial board equity and equality (gender, religious, social, cultural, racial). Our publication priorities and decisions are made keeping in mind the quality, originality, and utility of the submitted manuscripts. Nevertheless, we are aware that more inclusive policies are needed to modify recognised imbalances in biomedical publications.
ALIES is a non-profit Open Access publisher supporting all researchers, with emphasis on those from Portuguese speaking countries and communities, to use biomedical and biopharmaceutical knowledge published in BBR for social progress and science dissemination
Visit BBR Contact page for details.